JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
TRDA - Entrada Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary TRDA Stock
Financials
Financials TRDA Stock
Loading...
Loading...
Income Statement
Income Statement TRDA Stock
Balance Sheet
Balance Sheet TRDA Stock
Cash Flow Statement
Cash Flow Statement TRDA Stock
Loading...
Loading...
Home
Stocks
Entrada Therapeutics, Inc. (TRDA)
Financials
Financials of TRDA
Loading...
Loading...
Loading...
Loading...
TRDA Financials - Entrada Therapeutics Income & Cash Flow | Ledgeburg
Revenue
$25.421M
Operating Income
$-157.898M
Net Income
$-143.75M
Share Count (Basic)
41.371486M
Operating Cash Flow
$-128.512M
Free Cash Flow
$-129.553M
Cash And Short-Term Equivalents
$90.394M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
50M
100M
150M
200M
FY2023
FY2024
FY2025
Revenue $USD
0
5M
10M
15M
20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-150M
-100M
-50M
0
50M
Annual
Quarterly
Margins
Gross
Operating
Net
-600%
-400%
-200%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-40M
-30M
-20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-5000%
-4000%
-3000%
-2000%
-1000%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26